Switch to:
More From Other Websites
Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) as Extended Treatment for Recurrent or... Jan 19 2016
Daratumumab Data Published in The Lancet Shows Encouraging Efficacy in Heavily Pretreated and... Jan 07 2016
Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen Dec 21 2015
Genmab Announces Completion of Agreement to Transfer Remaining Ofatumumab Rights Dec 21 2015
Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen Dec 18 2015
Articles of Association for Genmab A/S Dec 18 2015
Genmab to Present at the 34th Annual J.P. Morgan Healthcare Conference Dec 15 2015
GENCOR INDUSTRIES INC Financials Dec 12 2015
Report Pursuant to Section 28a of the Danish Securities Trading Act Dec 10 2015
Grant of Restricted Stock Units to Board Members and Management and Grant of Warrants to Management... Dec 10 2015
GENCOR RELEASES FOURTH QUARTER AND FISCAL YEAR 2015 RESULTS Dec 09 2015
Gencor Industries, Inc.: Leading performance but fundamentals not looking strong? Dec 09 2015
Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen Dec 09 2015
GENCOR INDUSTRIES INC Files SEC form 10-K, Annual Report Dec 09 2015
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 09 2015
Gencor reports 4Q loss Dec 08 2015
Gencor reports 4Q loss Dec 08 2015
Gencor Releases Fourth Quarter and Fiscal Year 2015 Results Dec 08 2015
Genmab's 2015 R&D Update Live from Orlando Dec 08 2015
Genmab to Hold R&D Update on Company's Progress in 2015 Dec 04 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK